Table 4 Univariate analyses of mortality at 3 months after SE onset

Age, median (IQR), years

66(53,75)

75(59,87)

65(47.5,71)

0.011*

–

Gender, male, No. (%)

61(61.0%)

12(52.2%)

49(63.6%)

0.340

0.623(0.243–1.636)

History of prior seizures, No. (%)

33(33.0%)

3(13.0%)

30(39.0%)

0.023*

0.235(0.070–0.85)

Acute symptomatic etiology, No. (%)

50(50.0%)

14(60.9%)

36(46.8%)

0.342

1.772(0.713–4.329)

Potentially fatal etiology, No. (%)

51(51.0%)

18(78.3%)

33(42.9%)

0.004**

4.8(1.679–12.6)

Bilateral lesions/diffuse cerebral edema, No. (%)

49(49.0%)

10(43.5%)

39(50.6%)

0.637

0.750(0.292–1.862)

Interictal epileptiform activity, No. (%)

39(39.0%)

7(30.4%)

32(41.6%)

0.466

0.615(0.242–1.596)